Immunogenicity Testing

Immunogenicity is the ability of a particular substance induce a humoral and/or cell-mediated immune responses. An immune response can be potentially elicited by administering any substance into the human body.

Products which increase the potential of anti-drug antibodies include :

Therapeutic antibodies, enzyme therapies, peptides and combination products.

An immune response may also impact a drug’s safety and efficacy. Assays should be designed in such a way that they provide sufficient sensitivity and are free from potential risks to the target patient population. By designing assays with these factors, it is possible to gather data about the strength and type of immune response that a drug may produce in humans.

  • Bridging ELISA
  • Type II hypersensitivity reaction
  • Clinical Trial Support
  • Total Antibody Assay
  • Enzyme Linked Immuno Sorbent Assay (ELISA)

Related Conference of Immunogenicity Testing

July 29-30, 2019

2nd Annual Biotechnology Congress

| Chicago, Illinois, USA
August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
August 30-31, 2019

International Conference on Genetic Disorders

Bangkok, Thailand
September 03-04, 2019

International Conference On Genomics and Molecular Biology

Prague | Czech Republic
September 10-11, 2019

International Conference on Cell and Gene Therapy

| Prague, Czech Republic
September 13-14, 2019

12th World Congress on Cell & Tissue Science

Singapore
October 21-22, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
November 11-12, 2019

2nd International Conference on Epigenetics and Human Diseases

Amsterdam, Netherlands
November 11-12, 2019

6th World Congress on Epigenetics and Chromosome

Amsterdam, Netherlands
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
March 16-17, 2020 |

12th World Congress and Expo on Cell & Stem Cell Research

Chicago, Illinois, USA

Immunogenicity Testing Conference Speakers

Recommended Sessions

Related Journals

Are you interested in